XML 36 R18.htm IDEA: XBRL DOCUMENT
v3.23.3

Note 10 - Common Stock Options | 12 Months Ended
--- | ---
Sep. 30, 2023
Stock Option Plans [Member] |
Notes to Financial Statements |
Share-Based Payment Arrangement [Text Block] |
10. | COMMON STOCK OPTIONS
The KESOP provides for the issuance of common stock options to officers and certain other full-time salaried employees to acquire shares of the Company’s common stock. As of September 30, 2023, the number of shares available for future grants was 22,000. ASC 718, Compensation-Stock Compensation, requires that compensation expense be recognized for the issuance of equity instruments to employees. During the fiscal year ended September 30, 2022, the Board approved stock option grants to certain officers. As required by the KESOP, each option's exercise price per share equaled the fair value of the Company's common stock on the grant date. Pursuant to the plan, the options vest over a six-month period and are exercisable over a ten-year period from the date of issuance. No options were granted during the fiscal year ended September 30, 2023. As the Company's stock options are not traded on the open market, the fair value of each grant is estimated on the date of grant using the Black-Scholes option pricing model including the following assumptions:
|  | Years Ended September 30 |
|  | 2023 |  |  | 2022 |
Expected volatility |  |  | N/A |  |  |  | 31.79 | %
Expected dividends |  |  | N/A |  |  |  | 2.77 | %
Expected exercise term (years) |  |  | N/A |  |  |  | 7 |
Risk-free interest rate |  |  | N/A |  |  |  | 2.89 | %
The underlying methods regarding each assumption are as follows: Expected volatility is based on the historical volatility of the daily closing price of the Company's common stock. Expected dividend rate is based on historical dividend payout trends. Expected exercise term is based on the average time historical option grants were outstanding before being exercised. Risk-free interest rate is based on the 7-year Treasury rate on the date of option grant. Forfeitures are recognized when they occur. Stock option transactions under the Company's plans are summarized below.
|  | Number of Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Terms (years) |  |  | Aggregate Intrinsic Value(1) |
Options outstanding, September 30, 2021 |  |  | 45,250 |  |  | $ | 19.34 |  |  |  | 6.0 |  |  | $ | 213,898 |
Options granted |  |  | 6,000 |  |  |  | 19.90 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (8,750 | ) |  |  | 14.49 |  |  |  |  |  |  |  |  |
Options forfeited |  |  | (8,000 | ) |  |  | 27.87 |  |  |  |  |  |  |  |  |
Options outstanding, September 30, 2022 |  |  | 34,500 |  |  | $ | 18.69 |  |  |  | 5.7 |  |  | $ | 121,278 |
Options exercised |  |  | (12,500 | ) |  |  | 16.00 |  |  |  |  |  |  |  |  |
Options outstanding, September 30, 2023 |  |  | 22,000 |  |  | $ | 20.23 |  |  |  | 5.6 |  |  | $ | 18,388 |
Vested and exercisable at September 30, 2023 |  |  | 22,000 |  |  | $ | 20.23 |  |  |  | 5.6 |  |  | $ | 18,388 |
(1) Aggregate intrinsic value includes only those options where the exercise price is below the market price.
|  | Years Ended September 30 |
|  | 2023 |  |  | 2022 |
Weighted-average grant date option fair value |  | $ | — |  |  | $ | 5.39 |
Stock option expense |  |  | 21,560 |  |  |  | 16,330 |
Intrinsic value of options exercised |  |  | 46,921 |  |  |  | 58,944 |
Proceeds from exercise of stock options |  |  | 200,000 |  |  |  | 126,814 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=rgco_StockOptionPlansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |